Baylor University, a private Christian university and a nationally ranked research institution, provides a vibrant campus community for more than 15,000 students by blending interdisciplinary research with an international reputation for educational excellence and a faculty commitment to teaching and scholarship.

Baylor University 

New Row

Contact expert @[Full Name](fullname), @[Job Title](job_title) at @[Organization](organization) for media, speaking, professional opportunities and more.

@[Full Name](fullname) at @[Organization](organization) | Contact Form

Expert Inquiry

Open Sans

Distinguished Texas Scientist Award

Faculty Mentor

Outstanding Faculty Research Award

Maximizing Investigator’s Research Award

Research Exemplar

Board of Scientific Counselors – Basic Sciences

Gradipore Professor of Chemistry

Royal Society of Chemistry

American Chemical Society

Society for the Advancement of Chicanos and Native Americans in Science

Derivatization of ophiobolin A and cytotoxicity toward breast and glioblastoma cancer stem cells: Varying the ketone and unsaturated aldehyde moieties

Intramolecular epistasis correlates with divergence of specificity in promiscuous and bifunctional NSAR/OSBS enzymes

Combined HDAC and eIF4A inhibition: A novel epigenetic therapy for pancreatic ductal adenocarcinoma

Antioxidant, anti-tyrosinase, hepatoprotective, and anti-inflammatory potential in flowers and seeds of Ochna integerrima (Lour.) Merr

Gasdermin D Cleavage and Cytokine Release, Indicative of Pyroptotic Cell Death, Induced by Ophiobolin A in Breast Cancer Cell Lines

Dr. Daniel Romo serves as the Schotts Professor of Chemistry in Baylor University’s College of Arts and Sciences. A graduate of Texas A&M University (BA) and Colorado State University (PhD), he was also an American Cancer Society Post-Doctoral Fellow at Harvard University. In addition to teaching undergraduate and graduate courses, he also directs a research group at Baylor that focuses on the chemistry and biology of natural products, compounds isolated from natural sources (e.g.bacteria, marine sponges), leading to advances in basic cell biology and potential drug-leads through numerous local and international collaborations. For 32 years, the Romo Group has explored the de novo chemical synthesis of natural products and simplified, equipotent structural variants that are more readily synthesized. Their research is enabled by funding from the National Institutes of Health (MERIT and MIRA Awards), the National Science Foundation and the Welch Foundation.

As co-Director of Baylor’s Synthesis and Drug-Lead Discovery Laboratory, Dr. Romo seeks to translate basic discoveries emanating from his research laboratory to early pre-clinical studies and beyond through partnerships with other universities and pharma enabling advances in treatments for human diseases including cancer, Alzheimer's disease, and infection.

Before coming to Baylor, Dr. Romo was Gradipore Professor of Chemistry at Texas A&M and Director of the TAMU Undergraduate MiniPharma program, which he transplanted to Baylor. The Baylor Undergraduate MiniPharma program is a semi-autonomous, team-oriented approach to undergraduate research involving three teams performing chemical synthesis, molecular modeling and biological testing of a common natural product with potent bioactivity.

Organic Chemistry

Drug Discovery

Medicinal Chemistry

Cell Biology

Drug Lead Development

Small Molecules

Asymmetric Synthesis

Faculty Profile

Romo Research Group

Baylor Synthesis Lab (DL2)

OrganicLinks

Google Scholar Profile

LinkedIn

Chemistry professor advances cancer research

Baylor Chemist Among Innovators Advancing Oncology Treatment

Loving Science and Loving God

To pursue development of a groundbreaking drug to treat hypoxic-ischemic brain injury (HIBI) in newborns

Schotts Professor of Chemistry | Co-Director, Baylor Synthesis & Drug Lead Discovery Lab | Chair of OrganicLinks

Each year, cancer touches more than a million people in the U.S. alone. As part of Inauguration Week, some of Baylor University's leading cancer researchers shared how their callings have led to remarkable discoveries and promising results that advance detection and treatment of this complex disease. 

Panel participants:
* Dr. Linda Livingstone, President, Baylor University
* Dr. Michael McLendon, Interim Provost and Hale Endowed Professor in Higher Education Leadership and Policy, School of Education
* Dr. Kevin Pinney, professor of chemistry, College of Arts & Sciences, member of The Institute of Biomedical Studies
* Dr. Daniel Romo, The Schotts Professor of Chemistry, College of Arts & Sciences
* Dr. Touradj Solouki, professor of chemistry and biochemistry, College of Arts & Sciences
* Dr. Mary Lynn Trawick, associate professor of chemistry, College of Arts & Sciences

Baylor Inauguration Symposium: Unlocking Doors to Discovery in Health

This is a segment from TBN Salsa's "Raising the Standards" show #35.
This video is the property of Trinity Broadcasting Network and should not be reproduced without written consent.  If you do not receive TBN Salsa, please contact your local cable company to request the channel. To find out more visit: http://faithandeducation.com/raising-the-standards-tbn-salsa/

Raising The Standards Show #35 SHOW OPEN &amp; Interview with DANIEL ROMO

Dr. Daniel Romo - SpongeBob, Cancer, and Molecular Engineering - FYP Lecture Seriers

Select Inquiry Type